Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
According to the study, prolonged exposure to nitrogen dioxide, particulate matter PM2.5, and nitrogen oxide may raise the risk of dementia.
Read Full NewsFor patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.
1.
EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.
2.
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer
3.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
4.
Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening
5.
A paper strip test might enable the early detection of cancer.
1.
Obesity as a major risk factor for cancer
2.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
3.
Hemophilia: Pathophysiology, Genetics, and Treatment Advances
4.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
5.
Tumor Evolution: Signaling, Cancer Cell Plasticity, and Intratumor Heterogeneity
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XIV
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge